References
- Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood 2009;114:1469–1476.
- Straus DJ. How I treat mantle cell lymphoma. J Oncol Pract 2007;3:281–282.
- Bernard M, Tsang RW, Le LW, . Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital. Leuk Lymphoma 2012;53:XXX–XXX.
- Rosenbluth BD, Yahalom J. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT). Int J Radiat Oncol Biol Phys 2006;65: 1185–1191
- Leitch HA, Gascoyne RD, Chhanabhai M, . Limited-stage mantle-cell lymphoma. Ann Oncol 2003;14:1555–1561.
- Chandran R, Gardiner SK, Simon M, . Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007. Leuk Lymphoma 2012;53:1488–1493.
- Zhou Y, Wang H, Fang W, . Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer 2008;113:791–798.
- Romaguera JE, Medeiros LJ, Hagemeister FB, . Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer 2003;97:586–591.
- Salar A, Juanpere N, Bellosillo B, . Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol 2006;30:1274–1280.
- Brepoels L, Stroobants S, De Wever W, . Positron emission tomography in mantle cell lymphoma. Leuk Lymphoma 2008;49: 1693–1701.
- Hosein PJ, Pastorini VH, Paes FM, . Utility of positron emission tomography scans in mantle cell lymphoma. Am J Hematol 2011;86:841–845.
- Tsukamoto N, Kojima M, Hasegawa M, . The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-pet with 67gallium scintigraphy in the evaluation of lymphoma. Cancer 2007;110: 652–659.
- Elstrom R, Guan L, Baker G, . Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003;101:3875–3876.
- Martin P, Chadburn A, Christos P, . Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding seven years in a large cohort of patients managed primarily with conservative therapies. Blood 2007;110(Suppl. 1): Abstract 1362.